Review
doi: 10.2174/1389557043487510.
Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancer
Affiliations
- PMID: 14754444
- DOI: 10.2174/1389557043487510
Item in Clipboard
Review
Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancer
Mini Rev Med Chem.
2004 Jan.
Abstract
The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular administration of Cu-67 or Re-188 radiopharmaceuticals in the treatment of bladder cancer offers some promise for improvement in this situation.
Similar articles
-
Copper-67 as a therapeutic nuclide for radioimmunotherapy.Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):821-30. doi: 10.1007/s00259-001-0724-y. Epub 2002 Feb 2. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029558 Review.
-
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.J Nucl Med. 2001 May;42(5):726-32. J Nucl Med. 2001. PMID: 11337567
-
Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.Eur J Nucl Med. 1997 Apr;24(4):439-43. doi: 10.1007/BF00881818. Eur J Nucl Med. 1997. PMID: 9096097
-
Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.J Clin Oncol. 2000 Jan;18(2):363-70. doi: 10.1200/JCO.2000.18.2.363. J Clin Oncol. 2000. PMID: 10637251
-
Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.Adv Drug Deliv Rev. 2008 Sep;60(12):1389-401. doi: 10.1016/j.addr.2008.04.008. Epub 2008 Apr 23. Adv Drug Deliv Rev. 2008. PMID: 18547675 Review.
Cited by
-
188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy.Pharmaceuticals (Basel). 2017 Jan 19;10(1):12. doi: 10.3390/ph10010012. Pharmaceuticals (Basel). 2017. PMID: 28106830 Free PMC article. Review.
-
Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back.Theranostics. 2012;2(4):392-402. doi: 10.7150/thno.3722. Epub 2012 Apr 11. Theranostics. 2012. PMID: 22539935 Free PMC article.
-
The development of copper radiopharmaceuticals for imaging and therapy.Med Chem. 2011 Sep;7(5):413-29. doi: 10.2174/157340611796799177. Med Chem. 2011. PMID: 21711219 Free PMC article. Review.
-
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.Chem Rev. 2010 May 12;110(5):2858-902. doi: 10.1021/cr900325h. Chem Rev. 2010. PMID: 20415480 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
